Embecta Corp. (EMBC) closed the most recent trading day at $28.52, moving -1.82% from the previous trading session.
Embecta's (EMBC) diabetes care business is expected to have progressed in the fiscal second quarter banking on strong execution of its three strategic pillars.
Embecta Corp. (EMBC) closed at $27.36 in the latest trading session, marking a -1.12% move from the prior day.
In the latest trading session, Embecta Corp. (EMBC) closed at $29.46, marking a +0.58% move from the previous day.
Strong membership growth, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
EMBC, BNPQY, OLLI, CASY and JRVR have been added to the Zacks Rank #1 (Strong Buy) List on April 4, 2023.
HQI, EMBC and DTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 30, 2023.